tiprankstipranks
Eurofins Scientific (MX:ERFN)
LSE:ERFN
Mexico Market

Eurofins Scientific (ERFN) Ratios

Followers

Eurofins Scientific Ratios

MX:ERFN's free cash flow for Q2 2026 was €0.13. For the 2026 fiscal year, MX:ERFN's free cash flow was decreased by € and operating cash flow was €0.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.13 1.09 1.16 1.45 1.31
Quick Ratio
1.07 1.03 1.09 1.38 1.22
Cash Ratio
0.25 0.33 0.29 0.58 0.27
Solvency Ratio
0.15 0.15 0.20 0.17 0.23
Operating Cash Flow Ratio
0.55 0.53 0.63 0.48 0.64
Short-Term Operating Cash Flow Coverage
1.77 2.20 4.01 2.22 13.34
Net Current Asset Value
€ -4.64B€ -4.75B€ -3.05B€ -2.68B€ -2.92B
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.49 0.33 0.36 0.33
Debt-to-Equity Ratio
1.51 1.53 0.68 0.77 0.70
Debt-to-Capital Ratio
0.60 0.61 0.40 0.44 0.41
Long-Term Debt-to-Capital Ratio
0.56 0.55 0.33 0.36 0.36
Financial Leverage Ratio
3.07 3.10 2.04 2.14 2.11
Debt Service Coverage Ratio
1.35 1.68 2.57 1.87 6.82
Interest Coverage Ratio
4.79 4.93 4.82 4.23 7.42
Debt to Market Cap
0.44 0.44 0.32 0.29 0.22
Interest Debt Per Share
32.23 31.10 19.73 21.03 17.82
Net Debt to EBITDA
3.26 3.20 2.17 2.22 1.93
Profitability Margins
Gross Profit Margin
11.97%12.29%67.79%9.52%66.82%
EBIT Margin
12.44%11.23%10.00%8.48%13.19%
EBITDA Margin
20.18%19.86%19.88%18.68%21.97%
Operating Profit Margin
11.97%11.22%10.45%8.39%11.67%
Pretax Profit Margin
9.84%8.96%7.98%6.50%11.62%
Net Profit Margin
7.18%6.51%5.85%4.76%9.09%
Continuous Operations Profit Margin
7.14%6.48%5.83%4.72%9.01%
Net Income Per EBT
72.98%72.63%73.28%73.30%78.23%
EBT Per EBIT
82.21%79.92%76.37%77.41%99.59%
Return on Assets (ROA)
4.77%4.32%3.73%2.85%6.05%
Return on Equity (ROE)
14.81%13.41%7.61%6.11%12.76%
Return on Capital Employed (ROCE)
10.26%9.57%8.27%6.24%9.42%
Return on Invested Capital (ROIC)
6.83%6.38%5.74%4.24%7.14%
Return on Tangible Assets
9.26%8.42%7.73%5.60%13.15%
Earnings Yield
4.24%4.23%4.32%2.73%4.73%
Efficiency Ratios
Receivables Turnover
4.75 4.75 4.61 4.03 4.20
Payables Turnover
9.78 9.44 3.47 9.82 3.44
Inventory Turnover
44.83 46.04 15.78 42.40 15.30
Fixed Asset Turnover
2.73 2.64 2.72 2.84 3.10
Asset Turnover
0.66 0.66 0.64 0.60 0.67
Working Capital Turnover Ratio
26.85 25.83 10.80 8.77 13.37
Cash Conversion Cycle
47.61 46.15 -3.03 62.04 4.56
Days of Sales Outstanding
76.81 76.89 79.14 90.60 86.85
Days of Inventory Outstanding
8.14 7.93 23.13 8.61 23.86
Days of Payables Outstanding
37.34 38.67 105.30 37.17 106.16
Operating Cycle
84.95 84.82 102.27 99.20 110.72
Cash Flow Ratios
Operating Cash Flow Per Share
7.78 7.19 6.92 5.28 5.90
Free Cash Flow Per Share
3.62 2.97 4.15 2.43 2.47
CapEx Per Share
4.16 4.22 2.77 2.85 3.43
Free Cash Flow to Operating Cash Flow
0.47 0.41 0.60 0.46 0.42
Dividend Paid and CapEx Coverage Ratio
1.59 1.49 2.11 1.37 1.33
Capital Expenditure Coverage Ratio
1.87 1.70 2.50 1.85 1.72
Operating Cash Flow Coverage Ratio
0.25 0.24 0.37 0.26 0.34
Operating Cash Flow to Sales Ratio
0.18 0.18 0.19 0.16 0.17
Free Cash Flow Yield
5.16%4.76%8.41%4.11%3.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
23.73 23.64 23.15 36.67 21.16
Price-to-Sales (P/S) Ratio
1.67 1.54 1.35 1.75 1.92
Price-to-Book (P/B) Ratio
3.45 3.17 1.76 2.24 2.70
Price-to-Free Cash Flow (P/FCF) Ratio
19.38 20.99 11.89 24.32 27.11
Price-to-Operating Cash Flow Ratio
9.16 8.67 7.13 11.18 11.36
Price-to-Earnings Growth (PEG) Ratio
0.78 0.99 0.72 -0.75 -0.94
Price-to-Fair Value
3.45 3.17 1.76 2.24 2.70
Enterprise Value Multiple
11.51 10.95 8.97 11.57 10.68
Enterprise Value
17.16B 15.87B 12.39B 14.08B 15.75B
EV to EBITDA
11.51 10.95 8.97 11.57 10.68
EV to Sales
2.32 2.18 1.78 2.16 2.35
EV to Free Cash Flow
27.02 29.67 15.68 30.10 33.08
EV to Operating Cash Flow
12.57 12.26 9.40 13.83 13.86
Tangible Book Value Per Share
-9.84 -9.78 -1.28 -1.09 -3.08
Shareholders’ Equity Per Share
20.63 19.68 28.01 26.32 24.84
Tax and Other Ratios
Effective Tax Rate
0.27 0.28 0.27 0.27 0.22
Revenue Per Share
42.08 40.53 36.47 33.77 34.87
Net Income Per Share
3.02 2.64 2.13 1.61 3.17
Tax Burden
0.73 0.73 0.73 0.73 0.78
Interest Burden
0.79 0.80 0.80 0.77 0.88
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 <0.01 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.02 0.02 0.02 0.02
Income Quality
2.57 2.73 2.38 3.28 1.46
Currency in EUR